nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP2D6—Parkinson's disease	0.957	1	CbGaD
Clemastine—Eletriptan—HTR7—Parkinson's disease	0.00112	0.0947	CrCbGaD
Clemastine—Encainide—CYP2D6—Parkinson's disease	0.00103	0.0867	CrCbGaD
Clemastine—Eletriptan—HTR1A—Parkinson's disease	0.000861	0.0726	CrCbGaD
Clemastine—Hydroxyzine—CYP2D6—Parkinson's disease	0.000751	0.0632	CrCbGaD
Clemastine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000706	0.0225	CbGpPWpGaD
Clemastine—Mesoridazine—DRD3—Parkinson's disease	0.000703	0.0592	CrCbGaD
Clemastine—Azelastine—CYP2E1—Parkinson's disease	0.00061	0.0514	CrCbGaD
Clemastine—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000606	0.0193	CbGpPWpGaD
Clemastine—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	0.000585	0.0186	CbGpPWpGaD
Clemastine—Mesoridazine—HTR1A—Parkinson's disease	0.000573	0.0483	CrCbGaD
Clemastine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000567	0.0181	CbGpPWpGaD
Clemastine—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	0.000567	0.018	CbGpPWpGaD
Clemastine—Thioridazine—HTR7—Parkinson's disease	0.000564	0.0475	CrCbGaD
Clemastine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000545	0.0173	CbGpPWpGaD
Clemastine—Thioridazine—DRD1—Parkinson's disease	0.000521	0.0439	CrCbGaD
Clemastine—Eletriptan—CYP2D6—Parkinson's disease	0.000517	0.0435	CrCbGaD
Clemastine—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	0.000512	0.0163	CbGpPWpGaD
Clemastine—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	0.000512	0.0163	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000509	0.0162	CbGpPWpGaD
Clemastine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000504	0.016	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000492	0.0157	CbGpPWpGaD
Clemastine—Mesoridazine—DRD2—Parkinson's disease	0.000487	0.041	CrCbGaD
Clemastine—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000476	0.0152	CbGpPWpGaD
Clemastine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000475	0.0151	CbGpPWpGaD
Clemastine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000456	0.0145	CbGpPWpGaD
Clemastine—Azelastine—CYP2D6—Parkinson's disease	0.000448	0.0377	CrCbGaD
Clemastine—Thioridazine—HTR1A—Parkinson's disease	0.000432	0.0364	CrCbGaD
Clemastine—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000431	0.0137	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000431	0.0137	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000406	0.0129	CbGpPWpGaD
Clemastine—Mesoridazine—HTR2A—Parkinson's disease	0.000376	0.0317	CrCbGaD
Clemastine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.000374	0.0119	CbGpPWpGaD
Clemastine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000371	0.0118	CbGpPWpGaD
Clemastine—Eletriptan—ABCB1—Parkinson's disease	0.000369	0.0311	CrCbGaD
Clemastine—Thioridazine—DRD2—Parkinson's disease	0.000367	0.0309	CrCbGaD
Clemastine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000359	0.0114	CbGpPWpGaD
Clemastine—Thioridazine—CYP2E1—Parkinson's disease	0.000353	0.0298	CrCbGaD
Clemastine—Mesoridazine—CYP2D6—Parkinson's disease	0.000344	0.029	CrCbGaD
Clemastine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000339	0.0108	CbGpPWpGaD
Clemastine—Loperamide—CYP2D6—Parkinson's disease	0.000337	0.0284	CrCbGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.000335	0.0107	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000334	0.0106	CbGpPWpGaD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000326	0.0104	CbGpPWpGaD
Clemastine—Azelastine—ABCB1—Parkinson's disease	0.00032	0.0269	CrCbGaD
Clemastine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00031	0.00988	CbGpPWpGaD
Clemastine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000302	0.0096	CbGpPWpGaD
Clemastine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000298	0.0095	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00029	0.00923	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000289	0.00921	CbGpPWpGaD
Clemastine—Thioridazine—HTR2A—Parkinson's disease	0.000284	0.0239	CrCbGaD
Clemastine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.000284	0.00903	CbGpPWpGaD
Clemastine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00028	0.0089	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000279	0.00887	CbGpPWpGaD
Clemastine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000276	0.00878	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00027	0.0086	CbGpPWpGaD
Clemastine—Thioridazine—CYP2D6—Parkinson's disease	0.000259	0.0219	CrCbGaD
Clemastine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000256	0.00814	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.000254	0.00807	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000248	0.00789	CbGpPWpGaD
Clemastine—Loperamide—ABCB1—Parkinson's disease	0.000241	0.0203	CrCbGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000235	0.00748	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000234	0.00746	CbGpPWpGaD
Clemastine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00022	0.007	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.000205	0.00653	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000203	0.00646	CbGpPWpGaD
Clemastine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000197	0.00627	CbGpPWpGaD
Clemastine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000194	0.00619	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.000189	0.00601	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.000183	0.00584	CbGpPWpGaD
Clemastine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000166	0.00529	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00016	0.00509	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00016	0.00508	CbGpPWpGaD
Clemastine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000159	0.00507	CbGpPWpGaD
Clemastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000158	0.00504	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000154	0.00489	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.000149	0.00474	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000146	0.00465	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000141	0.00448	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.00014	0.00446	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000139	0.00443	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000138	0.0044	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000135	0.00429	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.000133	0.00424	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000132	0.00421	CbGpPWpGaD
Clemastine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000131	0.00418	CbGpPWpGaD
Clemastine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000129	0.0041	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.000128	0.00408	CbGpPWpGaD
Clemastine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000127	0.00405	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000125	0.00397	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.000122	0.00387	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000118	0.00376	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000117	0.00372	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000115	0.00367	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000114	0.00364	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000113	0.00359	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.000111	0.00354	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000109	0.00348	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000107	0.00339	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000104	0.00332	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.000103	0.00329	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.000102	0.00326	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.0001	0.00319	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	9.89e-05	0.00315	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	9.89e-05	0.00315	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	9.87e-05	0.00314	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	9.68e-05	0.00308	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	9.68e-05	0.00308	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	9.67e-05	0.00308	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	9.37e-05	0.00298	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	9.16e-05	0.00292	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	9.16e-05	0.00292	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	9.03e-05	0.00288	CbGpPWpGaD
Clemastine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	8.96e-05	0.00285	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	8.86e-05	0.00282	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	8.79e-05	0.0028	CbGpPWpGaD
Clemastine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.59e-05	0.00274	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	8.49e-05	0.0027	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	8.47e-05	0.0027	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	8.47e-05	0.0027	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.37e-05	0.00266	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	8.16e-05	0.0026	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	8.08e-05	0.00257	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	8.01e-05	0.00255	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	7.63e-05	0.00243	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	7.51e-05	0.00239	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	7.37e-05	0.00234	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	7.34e-05	0.00234	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	7.25e-05	0.00231	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	7.14e-05	0.00227	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.03e-05	0.00224	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7e-05	0.00223	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	6.98e-05	0.00222	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	6.94e-05	0.00221	CbGpPWpGaD
Clemastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	6.93e-05	0.0022	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	6.9e-05	0.0022	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	6.9e-05	0.0022	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	6.87e-05	0.00219	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.78e-05	0.00216	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	6.58e-05	0.0021	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	6.45e-05	0.00205	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	6.45e-05	0.00205	CbGpPWpGaD
Clemastine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	6.43e-05	0.00205	CbGpPWpGaD
Clemastine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	6.34e-05	0.00202	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	6.28e-05	0.002	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	6.24e-05	0.00199	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.07e-05	0.00193	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.98e-05	0.0019	CbGpPWpGaD
Clemastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.93e-05	0.00189	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	5.84e-05	0.00186	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	5.72e-05	0.00182	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	5.72e-05	0.00182	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	5.71e-05	0.00182	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.55e-05	0.00177	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.47e-05	0.00174	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	5.31e-05	0.00169	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	5.23e-05	0.00167	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	5.17e-05	0.00164	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.97e-05	0.00158	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.6e-05	0.00146	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.58e-05	0.00146	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	4.57e-05	0.00146	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.57e-05	0.00145	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ND3—Parkinson's disease	4.56e-05	0.00145	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.56e-05	0.00145	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.53e-05	0.00144	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	4.52e-05	0.00144	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.51e-05	0.00144	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	4.51e-05	0.00144	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	4.34e-05	0.00138	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	4.31e-05	0.00137	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.29e-05	0.00136	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.29e-05	0.00136	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	4.25e-05	0.00135	CbGpPWpGaD
Clemastine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.21e-05	0.00134	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	4.16e-05	0.00133	CbGpPWpGaD
Clemastine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.15e-05	0.00132	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.06e-05	0.00129	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	4.03e-05	0.00128	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	3.91e-05	0.00125	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	3.89e-05	0.00124	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.88e-05	0.00123	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	3.86e-05	0.00123	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	3.78e-05	0.0012	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.77e-05	0.0012	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PENK—Parkinson's disease	3.69e-05	0.00117	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MAG—Parkinson's disease	3.69e-05	0.00117	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	3.66e-05	0.00117	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	3.65e-05	0.00116	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	3.65e-05	0.00116	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.46e-05	0.0011	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.46e-05	0.0011	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.46e-05	0.0011	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	3.42e-05	0.00109	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	3.37e-05	0.00107	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	3.31e-05	0.00105	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	3.31e-05	0.00105	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	3.17e-05	0.00101	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	3.13e-05	0.000998	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ND3—Parkinson's disease	2.98e-05	0.000949	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.98e-05	0.000949	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	2.92e-05	0.000929	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.8e-05	0.000892	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—OMD—Parkinson's disease	2.8e-05	0.000892	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.78e-05	0.000885	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	2.75e-05	0.000875	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	2.67e-05	0.000848	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.66e-05	0.000846	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	2.65e-05	0.000844	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.55e-05	0.000813	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.54e-05	0.000807	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.54e-05	0.000807	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.46e-05	0.000783	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.4e-05	0.000763	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGB—Parkinson's disease	2.32e-05	0.00074	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	2.32e-05	0.000738	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	2.31e-05	0.000736	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	2.28e-05	0.000725	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.26e-05	0.000719	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.26e-05	0.000719	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.26e-05	0.000719	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	2.23e-05	0.000711	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	2.16e-05	0.000688	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.16e-05	0.000687	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.14e-05	0.00068	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	2.02e-05	0.000643	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.96e-05	0.000623	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.96e-05	0.000623	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.66e-05	0.000528	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.64e-05	0.000522	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.58e-05	0.000504	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.57e-05	0.000499	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.57e-05	0.000498	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.56e-05	0.000496	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.45e-05	0.000462	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.44e-05	0.000458	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.44e-05	0.000457	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TH—Parkinson's disease	1.41e-05	0.00045	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.41e-05	0.000449	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.4e-05	0.000444	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.37e-05	0.000436	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.36e-05	0.000432	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.27e-05	0.000405	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.2e-05	0.000383	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.2e-05	0.000381	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.19e-05	0.00038	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.18e-05	0.000376	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.13e-05	0.000361	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.1e-05	0.00035	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.09e-05	0.000346	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.05e-05	0.000335	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.04e-05	0.00033	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.02e-05	0.000324	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.72e-06	0.000309	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.49e-06	0.000302	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.38e-06	0.000299	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TH—Parkinson's disease	9.25e-06	0.000294	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—APOE—Parkinson's disease	9.05e-06	0.000288	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.88e-06	0.000283	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	8.1e-06	0.000258	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	8.05e-06	0.000256	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—COMT—Parkinson's disease	7.86e-06	0.00025	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.83e-06	0.000249	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.81e-06	0.000249	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—INS—Parkinson's disease	7.73e-06	0.000246	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.72e-06	0.000246	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	7.45e-06	0.000237	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.41e-06	0.000236	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.19e-06	0.000229	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.89e-06	0.000219	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.36e-06	0.000202	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—APOE—Parkinson's disease	5.92e-06	0.000188	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—INS—Parkinson's disease	5.05e-06	0.000161	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IL6—Parkinson's disease	4.75e-06	0.000151	CbGpPWpGaD
